<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-18T07:39:24Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/206126" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/206126</identifier><datestamp>2025-12-05T13:16:17Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478798</setSpec><setSpec>col_2072_478917</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>A nationwide case–control study on cardiovascular and respiratory-related disorders in patients with gambling disorder in Sweden</dc:title>
   <dc:creator>Abdul Rahim, Yassir</dc:creator>
   <dc:creator>Fernández Aranda, Fernando</dc:creator>
   <dc:creator>Jiménez-Murcia, Susana</dc:creator>
   <dc:creator>Hakänsson, Anders</dc:creator>
   <dc:subject>Jocs d'atzar</dc:subject>
   <dc:subject>Malalties cardiovasculars</dc:subject>
   <dc:subject>Malalties de l'aparell respiratori</dc:subject>
   <dc:subject>Gambling</dc:subject>
   <dc:subject>Cardiovascular diseases</dc:subject>
   <dc:subject>Respiratory diseases</dc:subject>
   <dc:description>Objectives: We aimed to examine potential relationships and gender differences between cardiovascular disease (CVD), diabetes, obesity, respiratory-related disorders, and gambling disorder (GD). We hypothesized that (1) GD patients would be more likely than controls to have CVD, diabetes, obesity, and respiratory-related diseases; and (2) females with GD would be more likely than men with GD to have CVD, diabetes, obesity, and respiratory-related diseases.  Study design: National retrospective case-control study.  Methods: We used data from the Swedish National Board of Health and Welfare between 2005 and 2019. A total of 10,766 patients were included, and 3592 of them had GD. Every GD patient was matched with two age- and gender-matched controls. Patient data, including the history of medical diagnoses, were extracted. Descriptive statistics, Chi-squared and Fisher's exact tests were used to compare GD patients and controls.  Results: GD patients had a higher prevalence of CVD and respiratory-related disorders than controls. Diabetes rates were 5% for GD patients and 2% for controls; CVD (18% vs 12%); respiratory-related disease (7% vs 4%); and obesity (7% vs 3%). Women with a diagnosis of GD have a higher prevalence of obesity and somatic comorbidities other than diabetes compared to men.  Conclusions: This is the largest case-control study conducted to date showing GD patients have a higher prevalence of CVD, diabetes, obesity, and respiratory-related disorders than controls. Women with GD appear to be more susceptible than men to CVD, obesity, and respiratory-related disorders; however, this may be partially explained by differences in help-seeking behavior. Thus, our findings highlight the importance of early identification of GD patients who may also have somatic conditions requiring treatment. This can be accomplished by implementing a screening program for GD, CVD, diabetes, obesity, and respiratory-related disorders, and by including healthy lifestyle management strategies.</dc:description>
   <dc:date>2024-01-22T14:58:34Z</dc:date>
   <dc:date>2024-01-22T14:58:34Z</dc:date>
   <dc:date>2023</dc:date>
   <dc:date>2024-01-22T14:58:34Z</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>0033-3506</dc:identifier>
   <dc:identifier>https://hdl.handle.net/2445/206126</dc:identifier>
   <dc:identifier>739586</dc:identifier>
   <dc:identifier>37716175</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Reproducció del document publicat a: https://doi.org/https://doi.org/10.1016/j.puhe.2023.08.018</dc:relation>
   <dc:relation>Public Health, 2023, vol. 224, p. 45-50</dc:relation>
   <dc:relation>https://doi.org/https://doi.org/10.1016/j.puhe.2023.08.018</dc:relation>
   <dc:rights>cc-by (c) Royal Society for Public Health, 2023</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>6 p.</dc:format>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Elsevier</dc:publisher>
   <dc:source>Articles publicats en revistes (Ciències Clíniques)</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>